Haemonetics Corp.
HAE
Market Cap$4.7B
Close$
$92.68
4% downside
Current Fair Value
4% downsideOvervalued by 4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.70 Billion |
|---|---|
| Enterprise Value | $5.38 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $2.46 |
| Beta | 0.8 |
| Outstanding Shares | 50,786,117 |
| Avg 30 Day Volume | 509,465 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 37.15 |
|---|---|
| PEG | -718.74 |
| Price to Sales | 3.86 |
| Price to Book Ratio | 5.36 |
| Enterprise Value to Revenue | 4.24 |
| Enterprise Value to EBIT | 29.78 |
| Enterprise Value to Net Income | 42 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.92 |
Revenue Sources
No data
ESG Score
No data
About Haemonetics Corp.
CEO: Christopher Simon